ATE494909T1 - Zusammensetzungen mit antigen-komplexen,verfahren zu ihrer herstellung und verfahren zur verwendung derantigen-komplexe zur vakzinierung - Google Patents

Zusammensetzungen mit antigen-komplexen,verfahren zu ihrer herstellung und verfahren zur verwendung derantigen-komplexe zur vakzinierung

Info

Publication number
ATE494909T1
ATE494909T1 AT03811387T AT03811387T ATE494909T1 AT E494909 T1 ATE494909 T1 AT E494909T1 AT 03811387 T AT03811387 T AT 03811387T AT 03811387 T AT03811387 T AT 03811387T AT E494909 T1 ATE494909 T1 AT E494909T1
Authority
AT
Austria
Prior art keywords
antigen complexes
vaccination
production
compositions containing
antigens
Prior art date
Application number
AT03811387T
Other languages
English (en)
Inventor
Antonius Stegmann
Original Assignee
Bestewil Holding Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bestewil Holding Bv filed Critical Bestewil Holding Bv
Application granted granted Critical
Publication of ATE494909T1 publication Critical patent/ATE494909T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1275—Lipoproteins; Chylomicrons; Artificial HDL, LDL, VLDL, protein-free species thereof; Precursors thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Otolaryngology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT03811387T 2002-11-20 2003-11-20 Zusammensetzungen mit antigen-komplexen,verfahren zu ihrer herstellung und verfahren zur verwendung derantigen-komplexe zur vakzinierung ATE494909T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02102610 2002-11-20
EP0350638 2003-09-18
PCT/EP2003/013084 WO2004045641A2 (en) 2002-11-20 2003-11-20 Antigen-complexes

Publications (1)

Publication Number Publication Date
ATE494909T1 true ATE494909T1 (de) 2011-01-15

Family

ID=34379291

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03811387T ATE494909T1 (de) 2002-11-20 2003-11-20 Zusammensetzungen mit antigen-komplexen,verfahren zu ihrer herstellung und verfahren zur verwendung derantigen-komplexe zur vakzinierung

Country Status (5)

Country Link
EP (1) EP1578443B1 (de)
AT (1) ATE494909T1 (de)
AU (1) AU2003296592A1 (de)
DE (1) DE60335742D1 (de)
WO (1) WO2004045641A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491395B2 (en) 2002-11-20 2009-02-17 Bestewil Holding B.V. Compositions comprising antigen-complexes, method of making same as well as methods of using the antigen-complexes for vaccination
TWI329130B (en) * 2003-06-19 2010-08-21 Bestewil Holding Bv Functionally reconstituted viral membranes containing adjuvant
CA2792938C (en) * 2010-03-23 2018-07-31 Irm Llc Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc.
AU2018390797A1 (en) * 2017-12-19 2020-07-02 CSL Behring Lengnau AG Protein purification and virus inactivation with alkyl glycosides
CN117147882B (zh) * 2023-10-31 2024-01-26 中国农业科学院生物技术研究所 抗虫蛋白Cry 1Ah酶联免疫定量检测试剂盒及方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
DE3775783D1 (de) 1986-01-14 1992-02-20 Nederlanden Staat Verfahren zur herstellung immunologischer komplexe und diese enthaltende pharmazeutische zusammensetzung.
NZ224422A (en) 1987-05-05 1990-11-27 Molecular Eng Ass Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid
ES2135406T3 (es) 1991-05-08 1999-11-01 Schweiz Serum & Impfinst Virosomas de la influenza reconstituidos inmunoestimulantes e inmunopotencializadores y vacunas que los contienen.
US5936076A (en) 1991-08-29 1999-08-10 Kirin Beer Kabushiki Kaisha αgalactosylceramide derivatives
FR2771640B1 (fr) * 1997-12-03 2000-02-11 Inst Nat Sante Rech Med Micelles mixtes de lipopeptides pour l'induction d'une reponse immunitaire et leurs utilisations a des fins therapeutiques
US6733985B1 (en) * 1999-05-19 2004-05-11 International Technidyne Corporation Preparation of stable liquid and dried synthetic prothrombin time reagents
AU2001238478C1 (en) 2000-02-15 2006-11-09 Id Biomedical Corporation Of Quebec Proteosome influenza vaccine
US6338859B1 (en) * 2000-06-29 2002-01-15 Labopharm Inc. Polymeric micelle compositions

Also Published As

Publication number Publication date
DE60335742D1 (de) 2011-02-24
WO2004045641A3 (en) 2005-02-03
EP1578443A2 (de) 2005-09-28
AU2003296592A8 (en) 2004-06-15
WO2004045641A2 (en) 2004-06-03
EP1578443B1 (de) 2011-01-12
AU2003296592A1 (en) 2004-06-15

Similar Documents

Publication Publication Date Title
Bergmann-Leitner et al. Adjuvants in the driver’s seat: how magnitude, type, fine specificity and longevity of immune responses are driven by distinct classes of immune potentiators
IL189313A (en) Virus-like particles as virus-paramixo vaccines, a method for their preparation and use
IL150602A0 (en) Proteosome influenza vaccine
UA93855C2 (ru) Вакцина, способствует росту, базирующейся ha нейтрализующем эпитопе
DE60117164D1 (de) Impfstoffe mit erhöhter immunantwort und verfahren zur deren herstellung
ATE461295T1 (de) Verfahren und zusammensetzungen zur impfung von tieren mit prrsv-antigenen mit verbesserter immunogenität
WO2005037190A3 (en) Multiplex vaccines
DE602005025342D1 (de) Impfstoffzusammensetzungen mit virosomen und einem saponin-adjuvans
EP2368576A3 (de) Funktionell neu errichtete Virenmembranen mit Adjuvantien
WO2004026265A3 (en) Compositions and methods for treatment of herpesvirus infections
Martelet et al. Porcine dendritic cells as an in vitro model to assess the immunological behaviour of Streptococcus suis subunit vaccine formulations and the polarizing effect of adjuvants
ATE494909T1 (de) Zusammensetzungen mit antigen-komplexen,verfahren zu ihrer herstellung und verfahren zur verwendung derantigen-komplexe zur vakzinierung
WO2002053588A3 (en) Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia psittaci
WO2007020520A3 (en) Antigenic peptides and their use
WO2005012538A3 (en) Accelerated vaccination
ATE505482T1 (de) Impfstoff gegen infektiöses lachsanämievirus
WO2005117956A3 (en) Neisserial vaccines
WO2018030338A1 (ja) アジュバント組成物
DE60218463D1 (de) Untereiheitsimpfstoffe und verfahren zur deren herstellung
WO2002036160A3 (es) Método de obtención de estructuras antigénicas que potencian la reactividad cruzada específica
ATE404152T1 (de) Pathogene impstoffe und verfahren zur deren verwendung
DE60335139D1 (de) Virusähnliche partikel, verfahren zur herstellung und immunogene zusammensetzungen
WO2023133500A3 (en) Compositions and methods for multivalent immune responses
WO2024047091A3 (en) Veterinary compositions of modified virus-like particles of cmv and ngf antigens
CO5590972A2 (es) Una biomasa en particulas de embrion aviar para la produccion de antigenos en virus

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1578443

Country of ref document: EP